Evaluation of new drugs in small cell lung cancer: the activity of gemcitabine
Postmus, P.E.; Schramel, F.M.; Smit, E.F.
Seminars in Oncology 25(4 Suppl 9: 79-82
1998
ISSN/ISBN: 0093-7754 PMID: 9728590 Document Number: 497656
The evaluation of the activity of new drugs against small cell lung cancer (SCLC) is discussed and the results with gemcitabine are presented. Gemcitabine has activity against untreated SCLC. Preliminary results from an ongoing study also indicate activity in so-called resistant SCLC.
Document emailed within 1 workday
Related Documents
Le Chevalier, T. 1996: Single-agent activity of gemcitabine in advanced non-small cell lung cancer Seminars in Oncology 23(5 Suppl 10: 36-42Evans, W.K. 1997: Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module Seminars in Oncology 24(2 Suppl 7: S7
Bergman, A.M.; Pinedo, H.M.; Veerman, G.; Kuiper, C.M.; Peters, G.J. 1998: Increased sensitivity to gemcitabine of P-gP and MRP overexpressing human non-small cell lung cancer cell lines Advances in Experimental Medicine and Biology 431: 591-594
Furuse, K. 1999: Gemcitabine in the treatment of non-small cell lung cancer for elderly patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(7): 890-897
Thongprasert, S.; Chewaskulyong, B.; Pothirat, C. 2001: Combination of gemcitabine and cisplatin in advanced non-small cell lung cancer Journal of the Medical Association of Thailand 84(3): 397-401
Cucević, B.; Samarzija, M.; Baricević, D.; Jakopović, M.; Redzepi, G.; Samija, M. 2005: Gemcitabine in the first and second-line chemotherapy of advanced non-small cell lung cancer Collegium Antropologicum 29(2): 583-588
Thatcher, N.; Jayson, G.; Bradley, B.; Ranson, M.; Anderson, H. 1997: Gemcitabine: symptomatic benefit in advanced non-small cell lung cancer Seminars in Oncology 24(3 Suppl 8: S8
Yokoyama, A. 1999: Gemcitabine hydrochloride is a new anti-cancer agent which will be available in the patients with non-small cell lung cancer (NSCLC) in Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(7): 908-915
Wolf, H.; Jassem, E.; Cynowska, B.ła.; Damps, I.; Mierzejewska, E.; Słomiński, J.M. 2002: Chemotherapy of advanced non-small cell lung cancer with the combination of gemcitabine and cisplatin Pneumonologia i Alergologia Polska 70(1-2): 44-51
Ettinger, D.S. 2000: Gemcitabine/Alimta in locally advanced or metastatic non-small-cell lung cancer Oncology 14(7 Suppl 4: 49-52
Gatzemeier, U.; Manegold, C.; Eberhard, W.; Wilke, H.J.; Chomy, F.; Chomy, P.; Khayat, D.; Blatter, J.; Seeber, S.; Drings, P. 1998: Ifosfamide and gemcitabine: a phase Ii trial in advanced inoperable non-small cell lung cancer Seminars in Oncology 25(1 Suppl 2: 15-18
Ryo, H.; Toyama, K.; Isobe, K.; Sugino, K.; Sano, G.; Yamada, H.; Hiroi, M.; Hojyo, T.; Kimura, K. 2003: A phase I study of gemcitabine and irinotecan as second line treatment for advanced non-small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(2): 237-242
Zwitter, M.; Cufer, T.; Wein, W. 2001: Gemcitabine and vincristine: an effective outpatient regimen with low myelotoxicity for stage IV non-small cell lung cancer Neoplasma 48(3): 200-202
Liu, S.-j.; Di, L.-j.; Wang, J.; Li, R.; Yang, L.; Sun, H.; Zhang, M.-h.; Li, L.; Liu, J.-w.; Gao, Y.-j.; Sun, H.; Xu, G.-w. 2003: Phase Ii clinical trial on gemcitabine in the treatment of stage IIIB-IV non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 25(6): 584-586
Bunn, P.A. 1999: Triplet chemotherapy with gemcitabine, a platinum, and a third agent in the treatment of advanced non-small cell lung cancer Seminars in Oncology 26(1 Suppl 4: 25-30
Yokoyama, A.; Nakai, Y.; Yoneda, S.; Kurita, Y.; Niitani, H.; Taguchi, T. 1996: A late phase Ii study of LY188011 (Gemcitabine hydrochloride) in patients with non-small-cell lung cancer. Gemcitabine Cooperative Study Group B for Late Phase Ii Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(12): 1681-1688
Kaira, K.; Yanagitani, N.; Sunaga, N.; Imai, H.; Utsugi, M.; Kawata, T.; Hisada, T.; Shimizu, K.; Ishizuka, T.; Mori, M. 2009: Effective gemcitabine plus S-1 treatment in elderly non-small cell lung cancer patients with multiple bone metastases Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(2): 299-300
Huang, Y-juan.; Wu, Y-long.; Xie, S-xi.; Yang, J-ji.; Huang, Y-sheng.; Liao, R-qiang. 2007: Weekly gemcitabine as a radiosensitiser for the treatment of brain metastases in patients with non-small cell lung cancer: phase I trial Chinese Medical Journal 120(6): 458-462
Bianco, V.; Rozzi, A.; Tonini, G.; Santini, D.; Magnolfi, E.; Vincenzi, B.; D'Angelillo, R.; Marchei, P. 2002: Gemcitabine as single agent chemotherapy in elderly patients with stages III-IV non-small cell lung cancer (NSCLC): a phase Ii study Anticancer Research 22(5): 3053-3056
Syrigos, K.N.; Konstantinou, M.; Sepsas, E.; Papamichales, G.; Loullias, A.; Belenis, I.; Skottis, I.; Charpidou, A.; Roussos, C. 2007: Biweekly administration of docetaxel and gemcitabine as adjuvant therapy for stage II and IIIA non-small cell lung cancer: a phase II study Anticancer Research 27(4c): 2887-2892